David N. LeBard

David N. LeBard

Auto-generated profile, based on publicly available information

David N. LeBard

OpenEye, Cadence Molecular Sciences

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2022 in Journal of Chemical Information and Modeling
Verified
Journal Article
Open access
SZShe Zhang
She Zhang
JTJeff P. Thompson
Jeff P. Thompson
JXJunchao Xia
Junchao Xia
ABAnthony T. Bogetti
Anthony T. Bogetti
FYForrest York
Forrest York
DLDavid N. LeBard
David N. LeBard
Passive permeability of a drug-like molecule is a critical property assayed early in a drug discovery campaign that informs a medicinal chemist how well a compound can traverse biological membranes, such as gastrointestinal epithelial or restrictive organ barriers, so it can perform a specific therapeutic function. However, the challenge that remains is the development of a method, experimental or computational, which can both determine the permeation rate and provide mechanistic insights into the transport process to help with the rational design of any given molecule. Typically, one of the following three methods are used to measure the membrane permeability: (1) experimental permeation assays acting on either artificial or natural membranes; (2) quantitative structure–permeability relationship models that rely on experimental values of permeability or related pharmacokinetic properties of a range of molecules to infer those for new molecules; and (3) estimation of permeability from the Smoluchowski equation, where free energy and diffusion profiles along the membrane normal are taken as input from large-scale molecular dynamics simulations. While all these methods provide estimates of permeation coefficients, they provide very little information for guiding rational drug design. In this study, we employ a highly parallelizable weighted ensemble (WE) path sampling strategy, empowered by cloud computing techniques, to generate unbiased permeation pathways and permeability coefficients for a set of drug-like molecules across a neat 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine membrane bilayer. Our WE method predicts permeability coefficients that compare well to experimental values from an MDCK-LE cell line and PAMPA assays for a set of drug-like amines of varying size, shape, and flexibility. Our method also yields a series of continuous permeation pathways weighted and ranked by their associated probabilities. Taken together, the ensemble of reactive permeation pathways, along with the estimate of the permeability coefficient, provides a clearer picture of the microscopic underpinnings of small-molecule membrane permeation.

17 October 2024 in Journal of Chemical Information and Modeling
Verified
Journal Article
Open access
NVNeha Vithani
Neha Vithani
SZShe Zhang
She Zhang
JTJeffrey P. Thompson
Jeffrey P. Thompson
LPLara A. Patel
Lara A. Patel
ADAlex Demidov
Alex Demidov
DLDavid N. LeBard
David N. LeBard
Identification of cryptic pockets has the potential to open new therapeutic opportunities by discovering ligand binding sites that remain hidden in static apo structures of a target protein. Moreover, allosteric cryptic pockets can become valuable for designing target-selective ligands when the natural ligand binding sites are conserved in variants of a protein. For example, before an allosteric cryptic pocket was discovered, KRAS was considered undruggable due to its smooth surface and conservation of the GDP/GTP binding pocket across the wild type and oncogenic isoforms. Recent identification of the Switch-II cryptic pocket in the KRASG12C mutant and FDA approval of anticancer drugs targeting this site underscores the importance of cryptic pockets in solving pharmaceutical challenges. Here, we present a newly developed approach for the exploration of cryptic pockets using weighted ensemble molecular dynamics simulations with inherent normal modes as progress coordinates applied to the wild type KRAS and the G12D mutant. We performed extensive all-atomic simulations (>400 μs) with and without several cosolvents (xenon, ethanol, benzene), and analyzed trajectories using three distinct methods to search for potential binding pockets. These methods have been applied as a proof-of-concept to KRAS and have shown they can predict known cryptic binding sites. Furthermore, we performed ligand-binding simulations of a known inhibitor (MRTX1133) to shed light on the nature of cryptic pockets in KRASG12D and the role of conformational selection vs induced-fit mechanism in the formation of these cryptic pockets.

10 April 2023 in Living Journal of Computational Molecular Science
Verified
Journal Article
Open access
PDF file
ABAnthony T. Bogetti
Anthony T. Bogetti
JLJeremy M. G. Leung
Jeremy M. G. Leung
JRJohn D. Russo
John D. Russo
SZShe Zhang
She Zhang
JTJeff P. Thompson
Jeff P. Thompson
LCLillian T. Chong
Lillian T. Chong
The weighted ensemble (WE) strategy has been demonstrated to be highly efficient in generating pathways and rate constants for rare events such as protein folding and protein binding using atomistic molecular dynamics simulations. Here we present two sets of tutorials instructing users in the best practices for preparing, carrying out, and analyzing WE simulations for various applications using the WESTPA software. The first set of more basic tutorials describes a range of simulation types, from a molecular association process in explicit solvent to more complex processes such as host-guest association, peptide conformational sampling, and protein folding. The second set ecompasses six advanced tutorials instructing users in the best practices of using key new features and plugins/extensions of the WESTPA 2.0 software package, which consists of major upgrades for larger systems and/or slower processes. The advanced tutorials demonstrate the use of the following key features: (i) a generalized resampler module for the creation of “binless” schemes, (ii) a minimal adaptive binning scheme for more efficient surmounting of free energy barriers, (iii) streamlined handling of large simulation datasets using an HDF5 framework, (iv) two different schemes for more efficient rate-constant estimation, (v) a Python API for simplified analysis of WE simulations, and (vi) plugins/extensions for Markovian Weighted Ensemble Milestoning and WE rule-based modeling for systems biology models. Applications of the advanced tutorials include atomistic and non-spatial models, and consist of complex processes such as protein folding and the membrane permeability of a drug-like molecule. Users are expected to already have significant experience with running conventional molecular dynamics or systems biology simulations.

16 June 2025 in ACS Omega
Verified
Journal Article
Open access
ABAnthony T. Bogetti
Anthony T. Bogetti
DYDarian T. Yang
Darian T. Yang
HPHannah E. Piston
Hannah E. Piston
DLDavid N. LeBard
David N. LeBard
LCLillian T. Chong
Lillian T. Chong
The weighted ensemble (WE) path sampling strategy has pushed the boundaries of molecular simulation by enabling the generation of rates and atomistic pathways for biological processes beyond the ms time scale. However, the WE strategy has not yet reached its full potential and much can be gained from pursuing “stress tests”. Here, we have explored a stress test involving the seconds-timescale unbinding of a highly charged ligand from a protein receptor: the release of the ADP ligand from the Eg5 protein receptor, which functions as a motor protein in cell division. From this stress test, we learned valuable lessons regarding the choice of progress coordinate and improvements to the WE resampling procedure. Based on the latter, we have developed a WE method referred to as the minimal adaptive binless (MABL) method. The MABL method is in the same spirit as our previously developed minimal adaptive binning scheme for surmounting large energetic barriers but is “binless”, i.e., does not require the use of rectilinear bins along a progress coordinate. This minimal version of a binless method is >50% more efficient than the corresponding binned version and provides a framework for implementing more complex binless methods.

3 March 2026 in The Journal of Chemical Physics
Verified
Journal Article
Closed access
WRWon Hee Ryu
Won Hee Ryu
JRJohn D. Russo
John D. Russo
MJMats S. Johnson
Mats S. Johnson
JCJeremy T. Copperman
Jeremy T. Copperman
JTJeffrey P. Thompson
Jeffrey P. Thompson
DZDaniel M. Zuckerman
Daniel M. Zuckerman
Weighted ensemble (WE) is a path-sampling method that is conceptually simple, widely applicable, and statistically unbiased. In a WE simulation, an ensemble of trajectories is periodically pruned or replicated to enhance the sampling of rare transitions and improve the estimation of mean first-passage times (MFPTs). However, poor choices of the parameters governing pruning and replication can lead to high variance in MFPT estimates. Our previous work [Aristoff et al., J. Chem. Phys. 158, 014108 (2023)] presented an optimal WE parameterization strategy and applied it to low-dimensional example systems. The strategy harnesses estimated local MFPTs from different initial configurations to a single target state. In the present work, we apply the optimal parameterization strategy to more challenging high-dimensional molecular models, namely, synthetic molecular dynamics (MD) models of Trp-cage folding and unfolding, as well as atomistic MD models of NTL9 folding in high-friction and low-friction continuum solvents. In each system, we use WE to estimate the MFPT for folding or unfolding events. We show that the optimal parameterization reduces the variance of MFPT estimates in three of four systems, with a dramatic improvement in the most challenging atomistic system. Overall, the parameterization strategy improves the accuracy and reliability of WE estimates for the kinetics of biophysical processes.

5 August 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
NVNeha Vithani
Neha Vithani
SZShe Zhang
She Zhang
JTJeffrey P. Thompson
Jeffrey P. Thompson
LPLara A. Patel
Lara A. Patel
ADAlex Demidov
Alex Demidov
DLDavid N. LeBard
David N. LeBard
Identification of cryptic pockets has the potential to open new therapeutic opportunities by discovering ligand binding sites that remain hidden in static apo structures of a target protein. Moreover, allosteric cryptic pockets can become valuable for designing target-selective ligands when the natural ligand binding sites are conserved in variants of a protein. For example, before an allosteric cryptic pocket was discovered, KRAS was considered undruggable due to its smooth surface and conservation of the GDP/GTP binding pocket across the wild type and oncogenic isoforms. Recent identification of the Switch-II cryptic pocket in the KRASG12C mutant and FDA approval of anti-cancer drugs targeting this site underscores the importance of cryptic pockets in solving pharmaceutical challenges. Here, we present a newly developed approach for the exploration of cryptic pockets using weighted ensemble molecular dynamics simulations with inherent normal modes as progress coordinates applied to the wild type KRAS and the G12D mutant. We performed extensive all-atomic simulations (> 400 microseconds) with and without several co-solvents (xenon, ethanol, benzene), and analyzed trajectories using three distinct methods to search for potential binding pockets. These methods have been applied as a proof-of-concept to KRAS and have shown they can predict known cryptic binding sites. Furthermore, we performed ligand-binding simulations of a known inhibitor (MRTX1133) to shed light on the nature of cryptic pockets in KRASG12D and the role of conformational selection vs induced-fit mechanism in the formation of these cryptic pockets.